U.S. Markets closed

Sage Therapeutics reports 4Q loss

CAMBRIDGE, Mass. (AP) _ Sage Therapeutics Inc. (SAGE) on Thursday reported a loss of $55.9 million in its fourth quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.50.

The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.14 per share.

For the year, the company reported that its loss widened to $159 million, or $4.75 per share.

Sage Therapeutics shares have risen 21 percent since the beginning of the year. The stock has climbed 87 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SAGE at https://www.zacks.com/ap/SAGE

_____

Keywords: Sage Therapeutics, Earnings Report